DL-3-Aminobutyric Acid>98.0%(T)1g

2-(4-Chloro-2-methylphenoxy)-1-(hydroxyimino)ethylamine, 50mg

Benzonitrile, 4-[5-[(1E)-2-[4-(2-chlorophenyl)-5-[5-(methylsulfonyl)-2-pyridinyl]-4H-1,2,4-triazol-3-yl]ethenyl]-1,3,4-oxadiazol-2-yl]-, 10mg

Ácido perrénico, solución (solución de hidroxotrioxorhenio (VII)) 25 g

(2R,4R)-1-Boc-2-Hydroxymethyl-4-aminopyrrolidinehydrochloride, 95.0%, 250mg

2-(1-tert-Butoxycarbonylpiperazin-4-yl)propionic acid, 97.0%, 1g

6-Amino-5-chloronicotinonitrile, 97.0%, 5g

2-(Difluoromethyl)-1-fluoro-4-nitrobenzene - stabilized over Potassium carbonate, 5g

Methyl 5-hexenoate, 95%, 10g

2-(benzylthio)-4-hydroxy-5-pyrimidinecarboxylic acid, 95.0%, 1g

2-Bromo-7-chlorobenzo[d]thiazole, 95.0%, 100mg

Molybdenum(VI) oxide, 99.5%, 25g

3-(2-Chloro-5-ethylpyrimidin-4-yl)-1H-indole, 97%, 250mg